Sohail Bakkar1, Marco Biricotti2, Gianni Stefanini2, Carlo Enrico Ambrosini2, Gabriele Materazzi2, Paolo Miccoli2. 1. Division of Endocrine Surgery, Department of Surgical Pathology, University Hospital of Pisa, Via Paradisa 2, 56124, Pisa, Italy. sohail.bakkar@gmail.com. 2. Division of Endocrine Surgery, Department of Surgical Pathology, University Hospital of Pisa, Via Paradisa 2, 56124, Pisa, Italy.
Abstract
PURPOSE: The optimal management of thyroglossal cyst carcinoma, particularly the extent of surgery required is controversial. The aim of this study was to evaluate the need for routinely adding total thyroidectomy to Sistrunk's operation in the management of this condition. METHODS: The clinical records of 19 patients with a diagnosis of thyroglossal cyst carcinoma encountered in an 11-year period (2004-2015) were reviewed. All patients underwent total thyroidectomy in addition to Sistrunk's procedure. The rate of concomitant thyroglossal cyst and thyroid carcinomas was calculated and cancers were staged according to the AJCC-TNM staging system. Patients were divided into two groups: those with thyroglossal cyst carcinoma only (group A) and those with a synchronous or metachronous thyroid carcinoma as well (group B). The need for radioactive iodine ablation in group A was assessed. The ability to omit total thyroidectomy based on thyroglossal cancer size and a negative thyroid ultrasound was also evaluated. RESULTS: The rate of concomitant thyroid cancer was 63.2 % (12/19). Based on stage, three out of the seven patients in group A required radioactive iodine ablation. Total thyroidectomy was ultimately justifiable in 78.9 % (15/19) of cases. Omitting total thyroidectomy in T1 thyroglossal cyst cancers or based on a sonographically normal thyroid was associated with a 43 % risk of missing thyroid malignancy. CONCLUSION: The routine addition of total thyroidectomy to Sistrunk's procedure seems to be appropriate for comprehensive loco-regional control especially that selecting a subset of patients in which it could be omitted is a difficult task.
PURPOSE: The optimal management of thyroglossal cyst carcinoma, particularly the extent of surgery required is controversial. The aim of this study was to evaluate the need for routinely adding total thyroidectomy to Sistrunk's operation in the management of this condition. METHODS: The clinical records of 19 patients with a diagnosis of thyroglossal cyst carcinoma encountered in an 11-year period (2004-2015) were reviewed. All patients underwent total thyroidectomy in addition to Sistrunk's procedure. The rate of concomitant thyroglossal cyst and thyroid carcinomas was calculated and cancers were staged according to the AJCC-TNM staging system. Patients were divided into two groups: those with thyroglossal cyst carcinoma only (group A) and those with a synchronous or metachronous thyroid carcinoma as well (group B). The need for radioactive iodine ablation in group A was assessed. The ability to omit total thyroidectomy based on thyroglossal cancer size and a negative thyroid ultrasound was also evaluated. RESULTS: The rate of concomitant thyroid cancer was 63.2 % (12/19). Based on stage, three out of the seven patients in group A required radioactive iodine ablation. Total thyroidectomy was ultimately justifiable in 78.9 % (15/19) of cases. Omitting total thyroidectomy in T1 thyroglossal cyst cancers or based on a sonographically normal thyroid was associated with a 43 % risk of missing thyroid malignancy. CONCLUSION: The routine addition of total thyroidectomy to Sistrunk's procedure seems to be appropriate for comprehensive loco-regional control especially that selecting a subset of patients in which it could be omitted is a difficult task.
Entities:
Keywords:
Papillary carcinoma; Sistrunk’s procedure; Thyroglossal cyst; Total thyroidectomy
Authors: L Pacheco-Ojeda; C Micheau; N Stafford; P Marandas; B Luboinski; A L Martinez Journal: Eur Arch Otorhinolaryngol Date: 1991 Impact factor: 2.503
Authors: Jackie Chou; Andrew Walters; Robert Hage; Anna Zurada; Maciej Michalak; R Shane Tubbs; Marios Loukas Journal: Surg Radiol Anat Date: 2013-05-21 Impact factor: 1.246
Authors: César P Ramírez Plaza; Marta E Domínguez López; Carmen Eloy-García Carrasco; Luis Martínez Meseguer; Agustín de la Fuente Perucho Journal: Ann Surg Oncol Date: 2006-03-16 Impact factor: 5.344
Authors: Gustavo Cancela E Penna; Henrique Gomes Mendes; Adele O Kraft; Cynthia Koeppel Berenstein; Bernardo Fonseca; Wagner José Martorina; Andreise Laurian N R de Souza; Gustavo Meyer de Moraes; Kamilla Maria Araújo Brandão Rajão; Bárbara Érika Caldeira Araújo Sousa Journal: Case Rep Endocrinol Date: 2017-02-08